DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Hung IF-N, Lung K-C, Tso EY-K. et al.
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Lancet 2020;
395 (10238): 1695-1704
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.